FDA to remove "black box" warnings on hormone therapies for menopause
2025-11-10 12:40:46 ET
More on Pfizer
- Pfizer Gets Metsera: Why The $20.65 CVR Is Highly Likely To Pay Out (In Part)
- Healthcare Q3 Dividend Roundup: I Prefer AbbVie Over Pfizer
- Pfizer: The Storm Has Passed -- Tailwinds Ahead
- Key deals this week: ITV-Sky, Metsera, Kyndryl, SM Energy, KNOT Offshore, Sonida Senior and more
- Novo Nordisk gives up battle for Metsera as Pfizer inks $10B deal
Read the full article on Seeking Alpha
For further details see:
FDA to remove “black box” warnings on hormone therapies for menopauseNASDAQ: TXMD
TXMD Trading
5.06% G/L:
$2.285 Last:
7,118 Volume:
$2.25 Open:



